Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19

• Published in: Journal of medical virology Vol. 92; no. 9; pp. 1533 - 1541
• Main Authors: Qu, Rong, Ling, Yun, Zhang, Yi‐hui‐zhi, Wei, Li‐ya, Chen, Xiao, Li, Xu‐mian, Liu, Xuan‐yong, Liu, Han‐mian, Guo, Zhi, Ren, Hua, Wang, Qiang
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2020; John Wiley and Sons Inc
• Subjects: Adult; Aged; Biomarkers; Coronaviridae; coronavirus disease; Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - diagnosis; COVID-19 - mortality; COVID-19 - virology; Cytokine Release Syndrome - blood; Cytokine Release Syndrome - etiology; Cytokine Release Syndrome - mortality; Cytokine storm; Cytokines; Female; Health services; Hospitalization; Humans; Leukocyte Count; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate analysis; Patients; Platelet Count; platelet value; Platelets; platelet‐to‐lymphocyte ratio; Pneumonia; Prognosis; risk factor; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Viral diseases; Virology; platelet-to-lymphocyte ratio; coronavirus disease; cytokine storm; risk factor; platelet value
• ISSN: 0146-6615; 1096-9071; 1096-9071
• DOI: 10.1002/jmv.25767

Since December 2019, novel coronavirus infected pneumonia emerged in Wuhan city and rapidly spread throughout China. In severe novel coronavirus pneumonia cases, the number of platelets, their dynamic changes during the treatment, platelet‐to‐lymphocyte ratio (PLR) were a concern. We sought to describe the platelet feature of these cases. Single‐center case series of the 30 hospitalized patients with confirmed coronavirus disease (COVID)‐19 in Huizhou municipal central hospital from January 2020 to February 2020 were retrospectively analyzed. Demographic, clinical, blood routine results, other laboratory results, and treatment data were collected and analyzed. Outcomes of severe patients and nonsevere patients were compared. Univariate analysis showed that: age, platelet peaks, and PLR at peak platelet were the influencing factors in severe patients, multivariate analysis showed that the PLR value at peak platelet during treatment was an independent influencing factor in severe patients. The average hospitalization day of patients with platelet peaks during treatment was longer than those without platelet peaks (P < .05). The average age of patients with platelet peaks during treatment was older than those without platelet peaks (P < .05). The patients with significantly elevated platelets during treatment had longer average hospitalization days. And the higher PLR of patients during treatment had longer average hospitalization days. Single‐center case series of the 30 hospitalized patients with confirmed COVID‐19 in Huizhou Municipal Central Hospital, presumed that the number of platelets and their dynamic changes during the treatment may have a suggestion on the severity and prognosis of the disease. The patient with markedly elevated platelets and longer average hospitalization days may be related to the cytokine storm. The PLR of patients means the degree of cytokine storm, which might provide a new indicator in the monitoring in patients with COVID‐19.